Your browser doesn't support javascript.
loading
A memorandum of understanding has facilitated guideline development involving collaborating groups.
Alam, Murad; Getchius, Thomas Sd; Schünemann, Holger; Amer, Yasser Sami; Bak, Aggie; Fatheree, Lisa A; Ginex, Pamela; Jakhmola, Priya; Marsden, Gemma L; McFarlane, Emma; Meremikwu, Martin; Taske, Nichole; Temple-Smolkin, Robyn L; Ventura, Christina; Burgers, Jako; Bradfield, Lisa; O'Brien, Mary Dolan; Einhaus, Kaitlin; Kopp, Ina B; Munn, Zachary; Scudeller, Luigia; Schaefer, Corinna; Ibrahim, Sarah A; Kang, Bianca Y; Ogunremi, Toju; Morgan, Rebecca L.
Afiliação
  • Alam M; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Departments of Dermatology, Surgery, and Otolaryngology, and Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: m-alam@northwestern.edu.
  • Getchius TS; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Guideline Strategy and Operations, American Heart Association/American College of Cardiology, Dallas, TX, USA.
  • Schünemann H; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Department of Health Research Methods, Evidence, and Impact; Michael G DeGroote Cochrane Canada and McMaster GRADE Centres; Department of Medicine; McMaster University, Hamilton, Ontario, Canada; Guidelines International
  • Amer YS; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Quality Management Department; Pediatrics Department; Research Chair for Evidence-Based Health Care and Knowledge Translation, Deanship of Scientific Research, King Saud University Medical City, King Saud University, Riy
  • Bak A; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Evidence Synthesis, Healthcare Infection Society, London, UK.
  • Fatheree LA; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Governance Services and Executive Operations, College of American Pathologists (CAP), Chicago, IL, USA.
  • Ginex P; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Evidence-based Practice, Oncology Nursing Society, Pittsburgh, PA, USA.
  • Jakhmola P; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Guideline Development, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Marsden GL; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Research & Development, Healthcare Infection Society, London, UK.
  • McFarlane E; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Centre for Guidelines, National Institute for Health and Care Excellence, Manchester, UK.
  • Meremikwu M; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Cochrane Nigeria, University of Calabar, Calabar, Nigeria.
  • Taske N; Guidelines International Network (GIN), Guidelines Collaboration Working Group; National Institute for Health and Care Excellence, Manchester, UK.
  • Temple-Smolkin RL; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Association for Molecular Pathology, Rockville, MD, USA.
  • Ventura C; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, IL, USA.
  • Burgers J; Dutch College of General Practitioners, Utrecht, The Netherlands; Care and Public Health Research Institute, Department Family Medicine, Maastricht University, Maastricht, The Netherlands.
  • Bradfield L; American Society for Radiation Oncology, Arlington, VA, USA.
  • O'Brien MD; American Academy of Neurology, Minneapolis, MN, USA.
  • Einhaus K; American Society of Clinical Oncology, Alexandria, VA, USA.
  • Kopp IB; Guidelines International Network (GIN) Board of Trustees; Association of the Scientific Medical Societies' Institute for Medical Knowledge-Management (AWMF-IMWi), Philipps-University, Marburg, Germany.
  • Munn Z; Guidelines International Network (GIN) Board of Trustees; Joanna Briggs Institute, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
  • Scudeller L; Medical Guidelines Director, European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland; Research and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Schaefer C; Departments for Evidence Based Medicine/Guidelines and Patient Information/Patient Involvement, German Agency for Quality in Medicine (AQuMed), Berlin, Germany.
  • Ibrahim SA; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Kang BY; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Ogunremi T; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
  • Morgan RL; Guidelines International Network (GIN), Guidelines Collaboration Working Group; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
J Clin Epidemiol ; 144: 8-15, 2022 04.
Article em En | MEDLINE | ID: mdl-34923026
ABSTRACT

OBJECTIVE:

Collaboration between groups can facilitate the development of high-quality guidelines. While collaboration is often desirable, misunderstandings can occur. One method to minimize misunderstandings is the pre-specification of terms of engagement in a memorandum of understanding (MOU). This study considered when an MOU may be most helpful, and which key elements should be included. STUDY DESIGN AND

SETTING:

An international panel of representatives from guideline groups was convened. A literature review to identify publications and other documents relevant to the establishment of MOUs between two or more guideline groups, supplemented by available source documents, was used to inform development of a draft MOU resource. This was iteratively refined until consensus was achieved.

RESULTS:

The level of detail in an MOU may vary based on institutional preferences and the particular collaboration. Elements within an MOU include those pertaining to (1) scope and purpose; (2) leadership and team; (3) methods and commitment; (4) review and endorsement; and (5) publication and dissemination.

CONCLUSION:

Since groups may have different expectations regarding how a collaboration will unfold, an MOU may mitigate preventable misunderstandings. The result may be a higher likelihood of producing a guideline without disruption and delay.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article